EUVIMEDEUVIMED entdecken
Crossref

Clotrimazole is effective, safe and tolerable for the treatment of endometriosis and functions by downregulating inducible nitric oxide synthase and modulating oxidative stress biomarkers

Daniel Escorsim Machado, Enrico Mendes Saggioro, Sidney Fernandes Sales Junior, Jéssica Alessandra-Perini, Luciana de Campos Gomes Diniz, Wagner Santos Coelho, Patrícia Zancan, Jamila Alessandra Perini

Molecular and Cellular Endocrinology · 2023

DOI: 10.1016/j.mce.2023.111883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2023. Verfasst von Daniel Escorsim Machado und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Pesquisa de Ciências Farmacêuticas, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Clotrimazole, Endometriosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the mechanism of action of clotrimazole (CTZ) and its adverse effects in a model of endometriosis. After autologous endometrial implantation, 18 rats were randomized into two treatment groups: 200 mg/kg CTZ or vehicle for 15 consecutive days. The lesion growth, implant size, glandular atrophy, nitric oxide (NO) serum levels, number of macrophage cells and inducible nitric oxide synthase (iNOS) immunoreactivity were significantly reduced in the CTZ group compared with the control. CTZ (p < 0.05) reduced the lipid peroxidation and protein carbonylation levels in the liver but did not alter the superoxide dismutase (SOD), glutathione (GSH) or glutathione S-transferase (GST) levels in the brain; however, the drug significantly reduced SOD activity and enhanced GST activity in the liver. These results suggest that CTZ interferes with reactive nitrogen species production by downregulating iNOS expression and thus enhances the antioxidant system to promote atrophy and regression of endometriotic lesions, without adverse effects on the brain and/or liver.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClotrimazoleEndometriosisFemaleHumansRatsAnimalsNitric Oxide Synthase Type IIOxidative StressAntioxidantsGlutathioneSuperoxide DismutaseLipid PeroxidationNitric OxideBiomarkers

Stichwörter der Autor:innen

Antioxidant systemClotrimazoleEndometriosisOxidative stressTreatment

Substanzen

Nitric Oxide Synthase Type IIClotrimazoleAntioxidantsGlutathioneSuperoxide DismutaseNitric OxideBiomarkers

Autor:innen und Institutionen

  • Laboratório de Pesquisa de Ciências Farmacêuticas, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
  • Programa de Pós-Graduação em Saúde Pública e Meio Ambiente, Escola Nacional de Saúde Pública Sérgio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil; Laboratório de Avaliação e Promoção da Saúde Ambiental, Fund…
  • Programa de Pós-Graduação em Saúde Pública e Meio Ambiente, Escola Nacional de Saúde Pública Sérgio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.
  • Laboratório de Oncobiologia Molecular, Departamento de Biotecnologia Farmacêutica, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  • Laboratório de Pesquisa de Ciências Farmacêuticas, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil. Electronic address: jamilaperini@yahoo.com.br.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Zitieren

APA

Machado, D. E., Saggioro, E. M., Sales Junior, S. F., Alessandra-Perini, J., de Campos Gomes Diniz, L., Coelho, W. S., Zancan, P., & Perini, J. A. (2023). Clotrimazole is effective, safe and tolerable for the treatment of endometriosis and functions by downregulating inducible nitric oxide synthase and modulating oxidative stress biomarkers. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2023.111883

Vancouver

Machado DE, Saggioro EM, Sales Junior SF, Alessandra-Perini J, de Campos Gomes Diniz L, Coelho WS, et al. Clotrimazole is effective, safe and tolerable for the treatment of endometriosis and functions by downregulating inducible nitric oxide synthase and modulating oxidative stress biomarkers. Molecular and Cellular Endocrinology. 2023. doi:10.1016/j.mce.2023.111883

BibTeX
@article{Machado2023,
  author = {Machado, Daniel Escorsim and Saggioro, Enrico Mendes and Sales Junior, Sidney Fernandes and Alessandra-Perini, Jéssica and de Campos Gomes Diniz, Luciana and Coelho, Wagner Santos and Zancan, Patrícia and Perini, Jamila Alessandra},
  title = {Clotrimazole is effective, safe and tolerable for the treatment of endometriosis and functions by downregulating inducible nitric oxide synthase and modulating oxidative stress biomarkers},
  journal = {Molecular and Cellular Endocrinology},
  year = {2023},
  doi = {10.1016/j.mce.2023.111883}
}
Kostenlos starten →